Genedata has launched Expressionist 5.3 with enhanced capabilities for transcriptomics-based biomarker discovery for applications in drug profiling and patient selection.
Specifically, Expressionist 5.3 expands the process capabilities of its Refiner Array module to support next-generation microarrays, including Affymetrix whole-transcript and exon arrays. For those using custom arrays, flexibility in pre-processing raw data has been increased by incorporating array type-specific layout information, Genedata said.
Additionally, the company said that the software includes enhanced data-quality assessment functionality, improved access to biological information, and optimized processing performance to enable efficient analysis of large-scale microarray projects.
Ambry Genetics said it has become an Agilent Certified Service Provider and is now certified to offer comparative genomic hybridization on the Agilent array platform.
ArrayIt has launched a biomarker discovery service. The firm said that it will run analysis of DNA or RNA samples on a custom microarray for a contract fee ranging from $100,000 to $1 million. It said that it will retain a "small percentage of each discovery as a downstream royalty."
NanoInk has launched a contract research program through its Nano BioDiscovery Division.
Using the Skokie, Ill.-based firms Dip Pen Nanolithography platform, NanoInk’s new contract research program includes a wide range of protein array services. Customers can choose from complete custom assay development and analysis projects to protein profiling work, to custom array printing, NanoInk said.